Cure LBSL (EIN 462829156) - Form 990 Financial Analysis & Trantor Score

🔒

Tuckman-Chang Vulnerability Assessment

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Principal Officer

Elizabeth A McGinn

Tax Period

2023-01-01 to 2023-12-31

A Cure For Ellie, founded in 2013, is a small nonprofit in the Diseases & Disorders sector that reported $108K in total revenue in fiscal year 2018.

Mission

Provide funding to rare disease research & support affected families

🔒

Trantor Score

Financial Health & Payment Capacity Assessment (FICO Scale: 300–850)

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $1,850,787

Program Service Revenue $0

Investment Income $1,765

Other Revenue $0

TOTAL REVENUE $1,852,552

Expense Breakdown

Grants Paid $1,502,459

Salaries & Benefits $84,131

Fundraising Expenses $0

Program Expenses $1,660,343

Other Expenses $75,075

TOTAL EXPENSES $1,661,665

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,852,552	$1,410,138	+0.3%
Expenses	$1,661,665	$1,319,933	+0.3%
Net Income	$190,887	$90,205	+1.1%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

⚠ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Morgan Stern	Director	1.00	Director	$0	$0	$0
Lance Stern	Director	1.00	Director	$0	$0	$0
Megan Mitchell	Director	1.00	Director	$0	$0	$0
Chris Gulugian	Director	1.00	Director	$0	$0	$0
Edward Blakely	Director	1.00	Director	$0	$0	$0
Michael McGinn until 724	Director	1.00	Director	$0	$0	$0
Elizabeth A McGinn	Director	15.00	Officer Director	$0	$0	$0
Elizabeth Gulugian	Board Chair	5.00	Officer Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,852,552	$1,661,665	$739,400	$190,887
2022	$1,410,138	$1,319,933	$535,129	$90,205
2021	$599,293	$414,562	$444,924	$184,731
2020	$659,411	$470,491	$260,193	$188,920
2019	$308,282	$279,767	$71,272	$28,515
2018	$107,860	$109,261	$43,192	$-1,401

Cure LBSL